1. P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study. (25th January 2019) Authors: Bar-Gil Shitrit, A; Siterman, M; Waterman, M; Hirsh, A; Khoury, T; Schwartz, D; Zittan, E; Adler, J; Koslowsky, B; Avni-Biron, I; Chowers, Y; Ron, Y; Israeli, E; Ungar, B; Yanai, H; Maharshak, N; Ben-Horin, S; Ben-Ya'acov, A; Eliakim, R; Dotan, I Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P768 Development and validation of Processed Foods Questionnaire (PFQ) in Israeli adult inflammatory bowel diseases patients. (25th January 2019) Authors: Sarbagili-Shabat, C; Zelber-Sagi, S; Fliss Isakov, N; Ron, Y; Hirsh, A; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P277 A new pan enteric capsule for suspected or established IBD: A feasibility study assessing the system functionality to visualise and assess the small and large bowels. (16th January 2018) Authors: Eliakim, R; Spada, C; Fernandez-Urien Sainz, I; Yanai, H; Lahat, A; Ron, Y; Pecere, S; Costamagna, G; Schwartz, A; Eyal, I; Lapidus, A; Adler, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018) Authors: Kopylov, U; Verstockt, B; Biedermann, L; Sebastian, S; Pugliese, D; Sonnenberg, E; Steinhagen, P R; Arebi, N; Ron, Y; Kucharzik, T; Roblin, X; Ungar, B; Bar-Gil Shitrit, A; Ardizzone, S; Molander, P; Coletta, M; Peyrin-Biroulet, L; Bossuyt, P; Avni-Biron, I; Tsoukal, E I Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P473 Real world experience with the Crohn's Disease Exclusion Diet (CDED) in a tertiary IBD clinic. (21st January 2022) Authors: Fliss Isakov, N; Anbar, R; Cooperstein, A; Helbert, G; Hirsch, A; Ron, Y; Thurm, T; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P583 Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicenter cohort study. (21st January 2022) Authors: Avni Biron, I; Mishael, T; Zittan, E; Livne, M; Zinger, A; Tzadok, R; Goldenberg, R; Kopylov, U; Ron, Y; Hadar, E; Helman, S; Ollech, J; Farkash, R; Pauker, M; Yanai, H; Dotan, I; Bar-Gil Shitrit, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P511 Disease-specific risk factors for malnutrition development in IBD. (27th May 2021) Authors: Einav, L; Hirsch, A; Ron, Y; Aviv Cohen, N; Anbar, R; Lahav, S; Maharshak, N; Fliss Isakov, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients. (27th May 2021) Authors: Tzadok, R; Fliss-Isakov, N; Aviv Cohen, N; Ron, Y; Maharshak, N; Hirsch, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience. (27th May 2021) Authors: Lichtenstein, L; Koslowsky, B; Avni-Biron, I; Ovadia, B; Ben-Bassat, O; Naftali, T; Kopylov, U; Haberman, Y; Banai Eran, H; Eliakim, R; Lahat-Zok, A; Hirsch, A; Zittan, E; Maharshak, N; Waterman, M; Israeli, E; Goren, I; Ollech, J E; Yanai, H; Ungar, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP68 Assessment of patients' understanding of Inflammatory Bowel Diseases (IBD): Development and validation of a questionnaire (U-IBDQ). (27th May 2021) Authors: Ostromohov, G; Fiebelman, M; Hirsch, A; Ron, Y; Aviv Cohen, N; Kariv, R; Deutsch, L; Anbar, R; Maharshak, N; Fliss Isakov, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗